Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

Download

• Small JPEG, 298x119, 60.6 KB
• Preview JPEG, 144x58, 40.9 KB
• Thumbnail JPEG, 120x48, 38.0 KB